This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q69561790
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в червні 1986 scientific article published on 01 June 1986 wetenschappelijk artikel im Juni 1986 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en xunu de 1986
p:P577
wds:Q69561790-5FA722C4-9576-47C2-A95B-1B9AB29AF683
wdt:P577
1986-06-01T00:00:00Z
p:P2093
wds:Q69561790-045A1172-86E5-430C-A710-EB50BDD1BE67 wds:Q69561790-2963CDCC-01ED-4C3C-AD61-76C29AEA638F wds:Q69561790-AD49B671-815B-43EF-A6C7-19318139D05D
wdt:P2093
P S Lietman R D Moore C R Smith
rdfs:label
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides
skos:prefLabel
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides
schema:name
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides
p:P1476
wds:Q69561790-D3B6BF73-75F5-4730-8E02-9A21B0A49033
wdt:P1476
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides
p:P304
wds:Q69561790-C7FE85CC-80A6-484C-B105-C7A6F54291CE
wdt:P304
1093-1097
p:P31
wds:Q69561790-E2E3AF75-4A0D-4568-A662-E341D4F85F0F
wdt:P31
wd:Q13442814
p:P921
wds:Q69561790-610B15D4-9862-4159-B2D3-255F7D406F81
wdt:P921
wd:Q929737
p:P698
wds:Q69561790-B7C0A907-5AB5-4ED9-98A3-70CCACFCFB6F
wdtn:P698
n10:3728506
wdt:P698
3728506
p:P1433
wds:Q69561790-41C633A9-58D4-40D4-91F3-995E0C1582CC
wdt:P1433
wd:Q2842959
p:P433
wds:Q69561790-5C85B9CA-0B8F-40AE-AEA8-69F2372394E8
p:P478
wds:Q69561790-A11CADAA-C515-4112-95C3-2DEF3607F99A
wdt:P433
6
wdt:P478
80
p:P356
wds:Q69561790-AE46B9E7-59C4-400E-83DC-D8D26C8FF5FB
wdtn:P356
n12:0002-9343(86)90670-4
wdt:P356
10.1016/0002-9343(86)90670-4